We are live on ! Find out more
NMRD

Nemaura Medical, Inc. Common Stock

Delisted

NMRD was delisted on the 4th of January, 2024.

3 hedge funds and large institutions have $48K invested in Nemaura Medical, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,700% more capital invested

Capital invested by funds: $1K → $48K (+$47K)

200% more funds holding

Funds holding: 13 (+2)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

Holders
3
Holders Change
+2
Holders Change %
+200%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
1
UBS Group
Switzerland
$30K +$23.2K +5,043 New
OIA
2
Optimum Investment Advisors
Illinois
$9K +$6.91K +1,500 New
Bank of America
3
Bank of America
North Carolina
$9K +$7.02K +1,523 New
Deutsche Bank
4
Deutsche Bank
Germany
-$1K -300 Closed

NMRD Hedge Fund Activity: Q1 2020 in Review

3 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q1 2020, worth a combined $48K — up 4,700% from $1K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NMRD positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $23.2K. The largest seller was Deutsche Bank, exiting entirely with an estimated $1K sold.

  • 3 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q1 2020, up from 1 in Q4 2019.
  • Funds reported $48K of Nemaura Medical, Inc. Common Stock stock for Q1 2020, up 4,700% quarter-over-quarter.
  • 3 funds opened new Nemaura Medical, Inc. Common Stock positions in Q1 2020 and 1 closed out, a net change of +2 holders.
  • The largest Nemaura Medical, Inc. Common Stock buyer in Q1 2020 was UBS Group, an estimated $23.2K added.
  • The largest Nemaura Medical, Inc. Common Stock seller in Q1 2020 was Deutsche Bank, an estimated $1K sold.

Based on aggregated 13F filings for Q1 2020.